Clinical trial
Expanded Access for Dasatinib
NCT00454753 · Bristol-Myers Squibb, Industry · No longer available
Key facts
| NCT number | NCT00454753 |
|---|---|
| Title | Expanded Access for Dasatinib |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Intervention type | Drug |
| Interventions | Dasatinib |
| First posted | Apr 2, 2007 |
| Last update posted | Apr 29, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: